NADPH oxidase inhibitors (Alimera)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNADPH oxidase inhibitors (Alimera)
Drug Alias NameNADPH oxidase inhibitors (Emory/Alimera)NADPH oxidase inhibitors (Emory University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADPH oxidase inhibitors
TargetsNADPH oxidase
Therapy Area/IndicationsRejection of organ transplantationHealthy AgingDiabetes Mellitus +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEmory University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlimera Sciences IncEmory University
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationHealthy AgingDiabetes Mellitus +[12] 

Other Information

ATC CodeN/A
Related LinksN/A